Shanghai InnoStar Bio-tech Co., Ltd. (SHA:688710)

SHA:688710 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1,493	1,287	1,370	1,158	1,255	638.77
Short-Term Investments	-	-	-	-	-	12.33
Cash & Short-Term Investments	1,493	1,287	1,370	1,158	1,255	651.1
Cash Growth	11.10%	-6.02%	18.25%	-7.69%	92.70%	223.82%
Accounts Receivable	374.72	329.62	359.88	273.91	228.07	139.5
Other Receivables	9.39	8.26	22.74	17.81	6.06	-
Receivables	384.11	337.88	382.62	291.72	234.13	139.54
Inventory	554.52	430.46	332.02	510.54	489.47	396.85
Other Current Assets	160.98	123.16	83.83	25.51	34.48	68.05
Total Current Assets	2,593	2,179	2,168	1,986	2,013	1,256
Property, Plant & Equipment	889.25	786.74	752.24	438.88	444.53	443.69
Other Intangible Assets	101.89	103.57	105.52	109.47	10.91	5.39
Long-Term Deferred Tax Assets	26.71	25.32	17.94	13.21	7.78	7.58
Long-Term Deferred Charges	63.34	66.8	70.45	77.02	81.57	73.78
Other Long-Term Assets	50.41	92.42	105.37	150.86	60.72	16.62
Total Assets	3,724	3,253	3,220	2,775	2,618	1,803

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	121.44	69	46.82	83.99	59.4	83.53
Accrued Expenses	93.72	86.29	75.88	75.29	65.6	60.73
Short-Term Debt	-	-	0.5	8.01	-	-
Current Portion of Long-Term Debt	-	-	-	-	-	39.06
Current Portion of Leases	15.87	11.09	29.28	23.39	17.57	17.91
Current Income Taxes Payable	1.82	-	5.12	2.98	7.13	9.46
Current Unearned Revenue	754.6	456.45	347.3	607.29	722	534.11
Other Current Liabilities	149.95	89.36	63.46	80.36	30	20.76
Total Current Liabilities	1,137	712.19	568.37	881.31	901.71	765.57
Long-Term Leases	114.39	104.59	201.32	215.1	229.23	239.28
Long-Term Unearned Revenue	64.37	68.47	41.34	38.78	45.76	43.34
Other Long-Term Liabilities	2.61	6.16	6.39	0.76	-	0
Total Liabilities	1,319	891.41	817.42	1,136	1,177	1,048

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	140.98	140.98	140.98	105.73	105.73	87.13
Additional Paid-In Capital	1,700	1,696	1,688	1,098	1,081	475.48
Retained Earnings	526.15	486.97	562.6	414.83	220.38	134.38
Comprehensive Income & Other	-0.8	-0.34	0.06	-	-	-
Total Common Equity	2,366	2,323	2,392	1,618	1,407	696.99
Minority Interest	39.04	38.58	10.19	21.42	34.35	57.43
Shareholders' Equity	2,405	2,362	2,402	1,639	1,442	754.41
Total Liabilities & Equity	3,724	3,253	3,220	2,775	2,618	1,803

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	130.26	115.68	231.1	246.5	246.8	296.25
Net Cash (Debt)	1,363	1,171	1,138	911.73	1,008	354.85
Net Cash Growth	13.77%	2.89%	24.87%	-9.54%	184.03%	119.03%
Net Cash Per Share	9.76	8.45	9.71	8.63	10.42	4.83
Filing Date Shares Outstanding	140.98	140.98	140.98	105.73	96.72	87.13
Total Common Shares Outstanding	140.98	140.98	140.98	105.73	96.72	87.13
Working Capital	1,455	1,466	1,600	1,105	1,111	489.97
Book Value Per Share	16.79	16.48	16.97	15.30	14.55	8.00
Tangible Book Value	2,265	2,220	2,286	1,509	1,396	691.59
Tangible Book Value Per Share	16.06	15.75	16.22	14.27	14.44	7.94
Buildings	144.74	232.08	103.59	44.04	25.53	24.35
Machinery	493.9	453.42	379.74	316.83	288.03	223.18
Construction In Progress	302.21	225.52	239.02	40.75	0.28	0.3

Data Source: S&P Global Market Intelligence Last updated: Aug 24, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 14, 2026

Data Sources Report a data error